Psychiatry Update 2021

Download All
GME’s Psychiatry Update 2021 series, now in its seventh year, is one of GME’s signature events. Review state-of-the-art diagnostic and therapeutic issues and options in patients with psychiatric illness. Download slides and supporting documents from expert insights on best practices and emerging data applicable to psychiatric illness.
Joseph F. Goldberg, MD
John M. Kane, MD
Craig L. Kratz, MD
Vladimir Maletic, MD
Greg W. Mattingly, MD
Joseph P. McEvoy, MD
Roger McIntyre, MD, FRCPC
Jonathan M. Meyer, MD

Recent Advances in Treating Bipolar Depressive Spectrum Disorders

Learn the latest about personalized treatment of patients with bipolar depression.

Joseph F. Goldberg, MD Roger McIntyre, MD, FRCPC Released: April 22, 2021

Bipolar Depressive Spectrum Disorders Webcast

In this interactive recording of a live CCO webinar, Roger McIntyre, MD, FRCPC, discusses diagnosing depressive episodes in individuals with bipolar disorder; clinical sub-characteristics that may influence treatment outcome; the limited role for use of antidepressants in bipolar depression; risk for lack of efficacy vs. treatment-emergent affective switch (TEAS); the antidepressant properties of mood stabilizers, second generation antipsychotics; and emerging novel therapeutics for depression in bipolar disorder.

Roger McIntyre, MD, FRCPC Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit Social Workers: 1.0 ACE CE Credit Psychologists: 1.0 APA CE Credit Released: January 31, 2022 Expired: January 30, 2023

Tardive Dyskinesia: An Expert’s Guide

Learn the latest about personalized treatment of patients with tardive dyskinesia.

John M. Kane, MD Jonathan M. Meyer, MD Released: April 22, 2021

Tardive Dyskinesia Webcast

In this interactive recording of a live CCO webinar, John M. Kane, MD, discusses a synopsis of tardive dyskinesia, traditional treatment approaches for tardive dyskinesia and their limitations, and recent research relating to the efficacy and safety of novel treatment options for tardive dyskinesia.

John M. Kane, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Physician Assistants: maximum of 0.75 hours of AAPA Category I CME credit Released: January 12, 2022 Expired: January 11, 2023

The Good, the Bad, and the Uncertain in the Treatment of Schizophrenia

Learn the latest about personalized treatment of patients with schizophrenia.

John M. Kane, MD Greg W. Mattingly, MD Joseph P. McEvoy, MD Released: April 22, 2021

Schizophrenia Webcast

In this interactive recording of a live CCO webinar, Greg Mattingly, MD, discusses unmet needs in the treatment of schizophrenia; evidence-based treatments, including the role of non-pharmacological therapies in schizophrenia; innovative treatments for the illness; and treatment choices, giving consideration to efficacy, safety, and long-term data.

Greg W. Mattingly, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit Social Workers: 1.0 ACE CE Credit Psychologists: 1.0 APA CE Credit Released: January 11, 2022 Expired: January 10, 2023

Different, Faster, and Maybe Better? Review of Novel Rapid-acting Antidepressants

Access up-to-date information about novel, rapid-acting antidepressants.

Vladimir Maletic, MD Released: April 22, 2021

COVID-19 and Mental Health: Assessment and Intervention

Learn the latest about personalized treatment of patients with COVID-19 and mental health issues.

Craig L. Kratz, MD Released: April 22, 2021

Glossary of Medications

Access this Glossary of Psychiatric Medications for a listing of common antidepressants, typical and atypical antipsychotics, common benzodiazepines, anxiolytics, hypnotics, mood stabilizers and more.

Released: April 22, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings